{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:58:08Z","timestamp":1780570688849,"version":"3.54.1"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi241318-4\"><jats:title>Importance<\/jats:title><jats:p>The American College of Surgeons (ACS) operative standards were established to detail critical elements of cancer surgery, reduce technical variation, and improve outcomes. Two of the 6 operative standards target adequate axillary surgery for breast cancer. The potential association of the operative standards with short-term oncologic outcomes, such as nodal yield and nodal positivity rates, is currently unknown.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241318-5\"><jats:title>Objective<\/jats:title><jats:p>To evaluate the potential association of the ACS operative standards with short-term oncologic outcomes in breast cancer.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241318-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>A cohort study was performed using data on 1\u202f201\u202f317 women 18 years or older who underwent sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) for invasive breast cancer from January 1, 2012, to December 31, 2020. Patients were identified using the National Cancer Database (NCDB), a clinical oncology database encompassing approximately 70% of new cancer diagnoses, sourced from hospital registry data from 1317 facilities. Statistical analysis was performed from October 2023 to June 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241318-7\"><jats:title>Exposure<\/jats:title><jats:p>Sentinel lymph node biopsy or ALND.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241318-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Reliability-adjusted facility-level lymph node yield and nodal positivity rate for each procedure were calculated using generalized linear mixed models, Poisson regression, and logistic regression with facility-level random intercepts.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241318-9\"><jats:title>Results<\/jats:title><jats:p>The cohort included 1\u202f201\u202f317 women with a median age of 62 years (IQR, 53-70 years). Facility-level nodal yield ranged from 1 to 6 for SLNB and from 6 to 22 for ALND. Median facility-level nodal yield for SLNB was 2.6 (IQR, 2.3-3.0) and the nodal positivity rate for SLNB was 12.2% (IQR, 11.0%-13.7%), with rates ranging from 6% to 21%. A weak correlation between facility-level lymph node yield and nodal positivity was observed (Spearman correlation coefficient, 0.17). Median nodal upstaging rate (\u22654 positive nodes) for ALND was 30.5% (IQR, 26.5%-35.0%), with rates ranging from 11% to 54%; median nodal yield was 12.2 (IQR, 10.9-13.6). A strong correlation between nodal yield and nodal upstaging rates was observed (Spearman correlation coefficient, 0.53).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241318-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cohort study of women undergoing axillary surgery for invasive breast cancer, facility-level variation in lymph node yield was present for both SLNB and ALND, which could potentially be improved through the ACS operative standards. However, this variation had mixed associations with nodal positivity and upstaging rates, suggesting the association of the ACS operative standards with oncologic outcomes may be mixed.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.46345","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T16:01:19Z","timestamp":1732118479000},"page":"e2446345","source":"Crossref","is-referenced-by-count":10,"title":["American College of Surgeons Operative Standards and Breast Cancer Outcomes"],"prefix":"10.1001","volume":"7","author":[{"given":"Crystal D.","family":"Taylor","sequence":"first","affiliation":[{"name":"Department of Surgery, Michigan Medicine, Ann Arbor"},{"name":"Center for Health Outcomes and Policy, Michigan Medicine, Ann Arbor"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"National Clinician Scholars Program, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison S.","family":"Baskin","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy","family":"Sinco","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes and Policy, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasha M.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Surgery, Michigan Medicine, Ann Arbor"},{"name":"Center for Health Outcomes and Policy, Michigan Medicine, Ann Arbor"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Boffa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut"},{"name":"American College of Surgeons Cancer Research Program, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[{"name":"American College of Surgeons Cancer Research Program, Chicago, Illinois"},{"name":"Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesly A.","family":"Dossett","sequence":"additional","affiliation":[{"name":"Department of Surgery, Michigan Medicine, Ann Arbor"},{"name":"Center for Health Outcomes and Policy, Michigan Medicine, Ann Arbor"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"American College of Surgeons Cancer Research Program, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"issue":"11","key":"zoi241318r1","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1245\/s10434-022-11375-w","article-title":"Technical Standards for Cancer Surgery: Commission on Cancer Standards 5.3-5.8.","volume":"29","author":"Katz","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"25","key":"zoi241318r2","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1200\/JCO.2008.21.7018","article-title":"Comparison of Commission on Cancer\u2013approved and \u2013nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base.","volume":"27","author":"Bilimoria","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi241318r4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.amjsurg.2005.10.031","article-title":"Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal?","volume":"191","author":"Woznick","year":"2006","journal-title":"Am J Surg"},{"issue":"7","key":"zoi241318r5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/jso.20878","article-title":"Sentinel lymph node biopsy for breast cancer: how many nodes are enough?","volume":"96","author":"Zakaria","year":"2007","journal-title":"J Surg Oncol"},{"issue":"1","key":"zoi241318r6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/cncr.23514","article-title":"How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?","volume":"113","author":"Yi","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"zoi241318r7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jso.25506","article-title":"Adherence to surgical and oncologic standards improves survival in breast cancer patients.","volume":"120","author":"Zhao","year":"2019","journal-title":"J Surg Oncol"},{"issue":"10","key":"zoi241318r8","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/1097-0142(19920515)69:10<2496::AID-CNCR2820691018>3.0.CO;2-T","article-title":"A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma.","volume":"69","author":"Kiricuta","year":"1992","journal-title":"Cancer"},{"issue":"4","key":"zoi241318r9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4048\/jbc.2011.14.4.296","article-title":"How many sentinel lymph nodes are enough for accurate axillary staging in t1-2 breast cancer?","volume":"14","author":"Ban","year":"2011","journal-title":"J Breast Cancer"},{"issue":"1","key":"zoi241318r10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41571-018-0089-9","article-title":"Progress in adjuvant systemic therapy for breast cancer.","volume":"16","author":"Pond\u00e9","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"9503","key":"zoi241318r12","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"issue":"9472","key":"zoi241318r13","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2005","journal-title":"Lancet"},{"issue":"7624","key":"zoi241318r14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"12","key":"zoi241318r15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the National Cancer Database for outcomes research: a review.","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"issue":"3","key":"zoi241318r16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"zoi241318r17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/SLA.0000000000002095","article-title":"The effect of hospital volume on breast cancer mortality.","volume":"267","author":"Greenup","year":"2018","journal-title":"Ann Surg"},{"issue":"6","key":"zoi241318r18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/cncr.30413","article-title":"Effect of hospital volume on processes of breast cancer care: a National Cancer Data Base study.","volume":"123","author":"Yen","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"zoi241318r19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/SLA.0b013e31824b46ff","article-title":"Reliability adjustment for reporting hospital outcomes with surgery.","volume":"255","author":"Dimick","year":"2012","journal-title":"Ann Surg"},{"issue":"3-4","key":"zoi241318r20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2307\/1422689","article-title":"The proof and measurement of association between two things. By C. Spearman, 1904.","volume":"100","author":"Spearman","year":"1987","journal-title":"Am J Psychol"},{"issue":"2","key":"zoi241318r22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.surg.2023.03.023","article-title":"Omitting axillary staging in selected patients: rationale of Choosing Wisely in breast cancer treatment.","volume":"174","author":"Grossi","year":"2023","journal-title":"Surgery"},{"issue":"12","key":"zoi241318r23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"10","key":"zoi241318r24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial.","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"zoi241318r25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jsurg.2018.02.020","article-title":"NSQIP analysis of axillary lymph node dissection rates for breast cancer: implications for resident and fellow participation.","volume":"75","author":"Nocera","year":"2018","journal-title":"J Surg Educ"},{"issue":"4","key":"zoi241318r26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.amjsurg.2019.07.013","article-title":"Decreasing rates of axillary lymph node dissections over time: implications for surgical resident exposure and operative skills development.","volume":"218","author":"Rosenberger","year":"2019","journal-title":"Am J Surg"},{"issue":"3","key":"zoi241318r27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10549-019-05500-9","article-title":"Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?","volume":"179","author":"Rosenberger","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"zoi241318r28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","article-title":"Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer\u2014results of the ALMANAC validation phase.","volume":"99","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"zoi241318r29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jso.10198","article-title":"Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.","volume":"82","author":"Petrik","year":"2003","journal-title":"J Surg Oncol"},{"issue":"8","key":"zoi241318r30","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/cncr.24964","article-title":"Number of lymph nodes removed in sentinel lymph node\u2013negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?","volume":"116","author":"Port","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"zoi241318r31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jso.20061","article-title":"Variability in axillary lymph node dissection for breast cancer.","volume":"87","author":"Schaapveld","year":"2004","journal-title":"J Surg Oncol"},{"issue":"3","key":"zoi241318r32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.suronc.2006.11.003","article-title":"Lymphedema following axillary lymph node dissection for breast cancer.","volume":"15","author":"Sakorafas","year":"2006","journal-title":"Surg Oncol"},{"issue":"1","key":"zoi241318r33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1309\/AJCPO92DZMUCGEUF","article-title":"To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting.","volume":"134","author":"Parkash","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"zoi241318r34","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1245\/s10434-022-11330-9","article-title":"Technical standards for cancer surgery: improving patient care through synoptic operative reporting.","volume":"29","author":"Hieken","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"zoi241318r35","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1245\/s10434-022-12417-z","article-title":"Editorial: updating the operative standards for cancer surgery key questions.","volume":"29","author":"Kelly","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"zoi241318r36","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1245\/s10434-021-10766-9","article-title":"New operative reporting standards: where we stand now and opportunities for innovation.","volume":"29","author":"Soegaard Ballester","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"zoi241318r37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.suronc.2011.02.004","article-title":"The evolving role of axillary lymph node dissection in the modern era of breast cancer management.","volume":"21","author":"Barry","year":"2012","journal-title":"Surg Oncol"},{"issue":"2","key":"zoi241318r38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jamaoncol.2017.3625","article-title":"Management of the node-positive axilla in breast cancer in 2017: selecting the right option.","volume":"4","author":"Morrow","year":"2018","journal-title":"JAMA Oncol"},{"issue":"2","key":"zoi241318r39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.48021","article-title":"Trends in sentinel lymph node biopsies in patients with inflammatory breast cancer in the US.","volume":"5","author":"Sosa","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"21","key":"zoi241318r40","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.2023.7271","article-title":"The volume and cost of quality metric reporting.","volume":"329","author":"Saraswathula","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"zoi241318r41","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection.","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"issue":"8","key":"zoi241318r43","first-page":"57","article-title":"NCDB and ACS-CRP: working together to develop risk-stratified strategies for surveillance.","volume":"99","author":"Chang","year":"2014","journal-title":"Bull Am Coll Surg"},{"key":"zoi241318r3","volume-title":"Optimal Resources for Cancer Care (2020 Standards)","author":"American College of Surgeons Commission on Cancer","year":"2020"},{"key":"zoi241318r11","unstructured":"Breast cancer (version 1.2024). National Comprehensive Cancer Network. Accessed February 3, 2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"key":"zoi241318r21","unstructured":"Choosing wisely. ABIM Foundation. Accessed April 24, 2024. https:\/\/www.choosingwisely.org\/clinician-lists\/sso-sentinel-node-biopsy-in-node-negative-women-70-and-over\/"},{"key":"zoi241318r42","unstructured":"Cancer program standards: ensuring patient-centered care. Commission on Cancer; American College of Surgeons. Accessed April 24, 2024. https:\/\/www.facs.org\/media\/t5spw4jo\/2016-coc-standards-manual_interactive-pdf.pdf?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2826509\/taylor_2024_oi_241318_1731448374.02018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T16:01:33Z","timestamp":1732118493000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2826509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.46345","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}